Our Horizons: Cell and Gene Therapy report, built on the inputs of nearly 150 advanced therapy medicinal product industry leaders, explores how leaders can future-proof ATMP manufacturing to meet varied and unforeseen health threats head-on.
Get CRB's Horizons report
Introducing Horizons, a new CRB editorial series exploring the key trends across the life sciences.
From the global COVID-19 pandemic to rare and vexing health threats, our world seems forever on the defense against disease and in need of a nimble and efficient vaccine and therapy supply chain.
Our Horizons: Cell and Gene Therapy report analyzes the manufacturing processes, efficiencies and solutions that shape the world’s response to pandemics and other large-scale health dangers. Sign up for your copy today.
Multimodal manufacturing—avoid challenges in the ATMP marketplace
Facing pressure in the ATMP marketplace? Multimodal manufacturing is your solution for that.
ATMP facilities: the cost of a manufacturing magic bullet
Essential strategies to position your ATMP facility for success.
5 considerations for a commercial-scale ATMP facility
Commercial scale is not far-off for advanced therapy medicinal product facilities.